Insulinaspart
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Diabetes & Endocrine treatment.
🧴 Clinical Application
Administered by subcutaneous injection 15 to 30 minutes before meals (for regular/premixed) or immediately before meals (for rapid analogues). Rotate injection sites systematically across the abdomen, thighs, buttocks, and upper arms. Gently invert cloudy NPH/biphasic suspensions 10-20 times before each dose to resuspend uniformly; do not shake vigorously.
⚠️ Side Effects
Common: Hypoglycemia (tremor, diaphoresis, palpitations, confusion), localized lipodystrophy, injection site redness, weight gain. Rare/Severe: Severe hypoglycemic coma, severe hypokalemia, and systemic hypersensitivity.
🛡️ Safety Warnings
High-alert medication; verify dose, units, and syringe scale (U-40 vs U-100) carefully before every injection. Always carry rapid-acting oral glucose or candy. Do not freeze. Unopened vials refrigerated (2-8°C); in-use vials room temperature (<25-30°C) for 28-42 days. Rotate injection sites to prevent lipohypertrophy.
Jan Aushadhi Products containing Insulinaspart
Found 1 generic formulation(s) containing this active ingredient.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Insulinaspart.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Insulin Aspart Injection 100IU per ml | 10ml Vial | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Insulinaspart generics.